SCR-LIP-000470 · Claim · machine-readable JSON →

In lipedema patients, platelet count, CRP, neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) were significantly higher than in controls (p<0.05), while MPV and PDW did not differ, and the inflammatory findings were not explained by BMI differences, supporting a low-grade systemic inflammatory component in lipedema.

This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
1 source(s)
Dates
2026-11-17 → 2026-11-17

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17

Evidence over time

2026Inflammatory Markers in Lipedema: A Comparative Analysis of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume (2026) · consistent

Evidence (1)

Context (PECO)

Populationpatients with lipedema vs controls
Conditionlipedema
Exposurelipedema diagnosis
Comparatorcontrols without lipedema
Outcomehematological inflammatory markers (NLR, PLR, MPV, PDW, CRP)
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log